Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda ... of a superior data package, including stability data ...

US inflation expected to have ticked up to 2.6% in October while core inflation (excluding food and energy) set to stay at ...

Pietro’s Trattoria broke ground for their new restaurant in Reynolds Ranch a couple weeks ago, according to owner Pete ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

Germany’s Bayer saw its shares tumble almost 11% to 21.76 euros this morning, as it reported level third-quarter 2024 sales ...

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer.

New analyses include... at 07:00 Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at ...

The maritime industry, a cornerstone of global trade, is undergoing a significant transformation through the adoption of digitalization and smart shipping technologies. As the industry navigates ...

Discover the secrets of Radio 4's iconic forecast for the seas around the British Isles.

Disney Cruise Line’s global team of cast, crew, and employees have been named as godparents of the new Disney Treasure.